DEA schedule
Is Combivent Respimat a controlled substance?
Combivent Respimat contains ipratropium bromide and albuterol. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Combivent Respimat (ipratropium bromide and albuterol) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ipratropium bromide and albuterol is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Combivent Respimat?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | ipratropium bromide and albuterol is not on the list |
Combivent Respimat NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0597-0024 | Combivent Respimat | spray, metered | 20 ug/1; 100 ug/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
Questions
Is Combivent Respimat a controlled substance?
No. Combivent Respimat (ipratropium bromide and albuterol) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ipratropium bromide and albuterol is not on the DEA controlled substances list.
Is Combivent Respimat a narcotic?
No. Combivent Respimat (ipratropium bromide and albuterol) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anticholinergic and beta2-Adrenergic Agonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.